Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 17:14:354.
doi: 10.1186/s12936-015-0892-z.

Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review

Dieudonné Makaba Mvumbi  1 , Jean-Marie Kayembe  2 , Hippolyte Situakibanza  3 , Thierry L Bobanga  4 , Célestin N Nsibu  5 , Georges L Mvumbi  6 , Pierrette Melin  7 , Patrick De Mol  8 , Marie-Pierre Hayette  9
Affiliations

Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review

Dieudonné Makaba Mvumbi et al. Malar J. .

Abstract

Background: Malaria cases were estimated to 207 million in 2013. One of the problems of malaria control is the emergence and spread of Plasmodium falciparum strains that become resistant to almost all drugs available. Monitoring drug resistance is essential for early detection and subsequent prevention of the spread of drug resistance by timely changes of treatment policy. This review was performed to gather all data available on P. falciparum molecular resistance in DR Congo, as baseline for future assessments.

Methods: The search for this review was undertaken using the electronic databases PubMed and Google Scholar using the terms "malaria", "Congo", "resistance", "molecular", "antimalarial", "efficacy". Articles were classified based on year of collecting, year of publication, sample size and characteristics, molecular markers analysed and polymorphisms detected.

Results: Thirteen articles were included and five genes have been analysed in these studies: pfcrt, pfdhps, pfdhfr, pfmdr1 and K13-propeller. The majority of studies included were not representative of the whole country.

Conclusion: This systematic review demonstrates the lack of molecular resistance studies in DRC. Only 13 studies were identified in almost 15 years. The MOH must implement a national surveillance system for monitoring malaria drug resistance and this surveillance should be conducted frequently and country-representative.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Search strategy. Twenty-one studies have been excluded after application of selection criteria
See this image and copyright information in PMC

References

    1. WHO . World malaria report 2014. Geneva: World Health Organization; 2014.
    1. Wellems T, Plowe C. Chloroquine-resistance malaria. J Infect Dis. 2001;184:770–776. doi: 10.1086/322858. - DOI - PubMed
    1. WHO. Antimalarial drug combination therapy. Report of a WHO technical consultation. Geneva: World Health Organization; 2001.
    1. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619–2620. doi: 10.1056/NEJMc0805011. - DOI - PubMed
    1. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–1966. doi: 10.1016/S0140-6736(12)60484-X. - DOI - PMC - PubMed

Publication types

MeSH terms